Correlation Between Polydex Pharmaceuticals and Madrigal Pharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Polydex Pharmaceuticals and Madrigal Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Polydex Pharmaceuticals and Madrigal Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Polydex Pharmaceuticals and Madrigal Pharmaceuticals, you can compare the effects of market volatilities on Polydex Pharmaceuticals and Madrigal Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Polydex Pharmaceuticals with a short position of Madrigal Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Polydex Pharmaceuticals and Madrigal Pharmaceuticals.

Diversification Opportunities for Polydex Pharmaceuticals and Madrigal Pharmaceuticals

0.18
  Correlation Coefficient

Average diversification

The 3 months correlation between Polydex and Madrigal is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Polydex Pharmaceuticals and Madrigal Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Madrigal Pharmaceuticals and Polydex Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Polydex Pharmaceuticals are associated (or correlated) with Madrigal Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Madrigal Pharmaceuticals has no effect on the direction of Polydex Pharmaceuticals i.e., Polydex Pharmaceuticals and Madrigal Pharmaceuticals go up and down completely randomly.

Pair Corralation between Polydex Pharmaceuticals and Madrigal Pharmaceuticals

Assuming the 90 days horizon Polydex Pharmaceuticals is expected to generate 0.49 times more return on investment than Madrigal Pharmaceuticals. However, Polydex Pharmaceuticals is 2.06 times less risky than Madrigal Pharmaceuticals. It trades about 0.09 of its potential returns per unit of risk. Madrigal Pharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  186.00  in Polydex Pharmaceuticals on August 31, 2024 and sell it today you would earn a total of  10.00  from holding Polydex Pharmaceuticals or generate 5.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy8.56%
ValuesDaily Returns

Polydex Pharmaceuticals  vs.  Madrigal Pharmaceuticals

 Performance 
       Timeline  
Polydex Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Polydex Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Polydex Pharmaceuticals is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders.
Madrigal Pharmaceuticals 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Madrigal Pharmaceuticals are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite quite uncertain technical and fundamental indicators, Madrigal Pharmaceuticals disclosed solid returns over the last few months and may actually be approaching a breakup point.

Polydex Pharmaceuticals and Madrigal Pharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Polydex Pharmaceuticals and Madrigal Pharmaceuticals

The main advantage of trading using opposite Polydex Pharmaceuticals and Madrigal Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Polydex Pharmaceuticals position performs unexpectedly, Madrigal Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Madrigal Pharmaceuticals will offset losses from the drop in Madrigal Pharmaceuticals' long position.
The idea behind Polydex Pharmaceuticals and Madrigal Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital